Search
Biomarker blood test could reveal high risk heart patients in need of treatment: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2019/biomarker-blood-test.html
A new blood test for protein biomarkers could identify high risk heart patients.
Can timing of food affect lifespan?: Newsroom - UT Southwestern, Dallas, TX
https://www.utsouthwestern.edu/newsroom/articles/year-2019/timing-of-food-lifespan.html
Dr. Joseph Takahashi, noted for discovering the first gene controlling biological clocks in mammals, addressed the topic at the Society for Neuroscience annual meeting where he was awarded the Gruber Neuroscience Prize for his pioneering work in circadian rhythms.
Three-drug combo improves lung function in most common genetic form of cystic fibrosis: Newsroom - UT Southwestern, Dallas, TX
https://www.utsouthwestern.edu/newsroom/articles/year-2019/three-drug-combo-cystic-fibrosis.html
A phase three clinical trial that UT Southwestern participated in determined that a three-drug combination improved lung function and reduced symptoms in cystic fibrosis (CF) patients who have a single copy of the most common genetic mutation for the disease.
Largest Texas high schools to report all concussions to statewide registry: Newsroom - UT Southwestern, Dallas, TX
https://www.utsouthwestern.edu/newsroom/articles/year-2019/texas-high-schools-report-concussions.html
Starting this fall, the biggest public high schools in Texas are required to report all sports concussions to a central database as part of one of the nation’s largest statewide endeavors to track brain injuries in youth athletics.
Study shows hunger-blocking hormone levels change with eating, obesity: Newsroom - UT Southwestern, Dallas, TX
https://www.utsouthwestern.edu/newsroom/articles/year-2019/hunger-hormone-blocker.html
The hormone LEAP2, which naturally blocks the “hunger” hormone ghrelin, is elevated in people with obesity, especially after eating – raising hopes for a treatment that could one day more effectively reduce appetite and, hence, obesity.
UT Southwestern molecular biologist to receive O'Donnell Award from TAMEST: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2024/jan-tamest-tagliabracci.html
Vincent Tagliabracci, Ph.D., Associate Professor of Molecular Biology at UT Southwestern Medical Center, will receive the 2024 Edith and Peter O’Donnell Award in Biological Sciences from the Texas Academy of Medicine, Engineering, Science and Technology (TAMEST) for broadening the understanding of
UT Southwestern levels the playing field for testicular cancer patients : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2020/testicular-cancer.html
Doctors were able to eliminate the effect of sociodemographic factors on patient outcomes by treating men at different hospitals with the same expert care
UT Southwestern, Texas Health launch collaborative study to better understand COVID prevalence in DFW - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2020/dfw-covid-prevalence-study.html
Despite the high number of confirmed cases, the true prevalence of COVID-19 infections is believed to be underestimated due to insufficient testing capacity and a high percentage of asymptomatic people.
Triple negative breast cancer meets its match: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2020/triple-negative-breast-cancer-meets-its-match.html
One member of a larger family of oxygen sensing enzymes could offer a viable target for triple negative breast cancer (TNBC), UTSW researchers report in a new study.
FDA-approved drugs could help fight COVID-19 - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2020/fda-approved-drugs-could-help-fight-covid19.html
Drugs that are already approved by the U.S. Food and Drug Administration (FDA) could hold promise in fighting the new infection known as coronavirus disease 2019 (COVID-19)...